Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Hisamitsu Pharmaceutical initiates phase III study of HP-5070 in Japan

Oct. 9, 2020

IDMC recommends piclidenoson psoriasis study continue, rheumatoid arthritis trial end

Oct. 8, 2020

Galapagos begins patient dosing with GLPG-3970 in psoriasis

Oct. 1, 2020

Arcutis reports topline phase II data on roflumilast topical foam for seborrheic dermatitis

Sep. 30, 2020

New IL-7 modulators discovered at Leo Pharma

Sep. 30, 2020

Japan first to approve Ecclock for primary axillary hyperhidrosis

Sep. 28, 2020

Hoth reports research findings on ability of HT-003 to block acne pathogenic gene expression

Sep. 28, 2020

Phase I data on NMT-cP12 support progression to phase II for severe burns

Sep. 25, 2020

Micreos begins phase I/IIa study of endolysin XZ.700 in atopic dermatitis

Sep. 23, 2020

Eli Lilly initiates phase II study of LY-3041658 in hidradenitis suppurativa

Sep. 22, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...